These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 32222367

  • 1. A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis.
    Ta CN, Raizman MB, Gross RD, Joshi S, Mallick S, Wang Y, Segal B.
    Am J Ophthalmol; 2020 Jul; 215():56-65. PubMed ID: 32222367
    [Abstract] [Full Text] [Related]

  • 2. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
    Pepose JS, Ahuja A, Liu W, Narvekar A, Haque R.
    Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732
    [Abstract] [Full Text] [Related]

  • 3. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
    Isenberg SJ, Apt L, Valenton M, Del Signore M, Cubillan L, Labrador MA, Chan P, Berman NG.
    Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
    Karpecki P, Depaolis M, Hunter JA, White EM, Rigel L, Brunner LS, Usner DW, Paterno MR, Comstock TL.
    Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis.
    Pepose JS, Narvekar A, Liu W, Haque R.
    Clin Ophthalmol; 2019 Mar; 13():535-544. PubMed ID: 30962674
    [Abstract] [Full Text] [Related]

  • 8. Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates.
    Sanfilippo CM, Allaire CM, DeCory HH.
    Drugs R D; 2017 Mar; 17(1):167-175. PubMed ID: 28078599
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
    Comstock TL, Paterno MR, Usner DW, Pichichero ME.
    Paediatr Drugs; 2010 Apr 01; 12(2):105-12. PubMed ID: 20218747
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recurrent conjunctivitis secondary to Gram-positive bacillus, Bacillus thuringiensis.
    Borgman CJ.
    Clin Exp Optom; 2018 Jul 01; 101(4):594-595. PubMed ID: 28626992
    [No Abstract] [Full Text] [Related]

  • 14. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
    Abelson MB, Heller W, Shapiro AM, Si E, Hsu P, Bowman LM, AzaSite Clinical Study Group.
    Am J Ophthalmol; 2008 Jun 01; 145(6):959-65. PubMed ID: 18374301
    [Abstract] [Full Text] [Related]

  • 15. Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis.
    Tepedino ME, Heller WH, Usner DW, Brunner LS, Morris TW, Haas W, Paterno MR, Comstock TL.
    Curr Med Res Opin; 2009 May 01; 25(5):1159-69. PubMed ID: 19323612
    [Abstract] [Full Text] [Related]

  • 16. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
    Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, Sherbany H, Mandelboim M.
    Acta Ophthalmol; 2017 Dec 01; 95(8):e686-e692. PubMed ID: 28342227
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Success of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study.
    Whiteside MM, Shorter ES, Margolis MS, Alvi F, Huecker JB, Than TP, Migneco MK, Harthan JS, Morettin CE, Hartwick ATE, Johnson SD, Perera CD, Gordon MO.
    Optom Vis Sci; 2021 May 01; 98(5):469-475. PubMed ID: 33973917
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.